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Introduction
Viral encephalitis is a medical emergency. Involvement of the CNS is an unusual
manifestation of human viral infection. The severity of brain involvement and the
prognosis depends mainly on the specific pathogen and the immunological state
of the host (1). Intranuclear inclusion bodies consistent with HSV infection were
first demonstrated in the brain of a neonate with encephalitis by Smith and others
in 1941(2).
Herpes Simplex Virus type 1 (HSV_1) is the major cause of devastating encephalitis,
with a predilection for the temporal lobes and a range of clinical presentations.
Despite of advances in antiviral therapy over the past two decades, Herpes Simplex
Virus Encephalitis (HSVE) has yet remained as a serious illness with significant
risks of morbidity and death(3).
Abstract:
Herpes Simplex encephalitis (HSE) is a life threatening outcome of Herpes
simplex virus (HSV) infection of the central nervous system (CNS). HSV
accounts for 2-5 percent of all cases of encephalitis.
One third of cases occur in those younger than 20 years old and one half
in those older than 50 years old.
Clinical diagnosis is recommended in the encephalopathic, febrile patients
with focal neurological signs. However, the clinical findings are not
pathogonomic because numerous other diseases of CNS can mimic HSE.
Diagnosis should be confirmed based on medical history, analysis of
cerebrospinal fluid (CSF) for protein and glucose contents, the cellular
analysis and identifying the pathogens by serology and Polymerase Chain
Reaction (PCR) amplification .
The diagnostic gold standard is the detection of HSV DNA in the cerebrospinal
fluid by PCR. But negative results need to be interpreted regarding the
patients clinical signs and symptoms and the time of CSF sampling. Spike
and slow wave patterns is observed in Electroencephalogram (EEG).
Neuroimaging, especially Magnetic Resonance Imaging (MRI) is essential
for evaluating the patients, which shows temporal lobe edema or hemorrhage.
All patients with HSE should be treated by intravenous Acyclovir (10mg/kg
q8hr for 14-21 days). After completing therapy, PCR of the CSF can confirm
the elimination of replicating virus, assisting further management of the
patient.
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This paper reviews the epidemiology, clinical presentation,
physical examinations, diagnosis, prognosis and treatment
of HSV-related diseases of the brain: encephalitis and
meningoencephalitis.
Methods
We reviewed the epidemiology, the clinical manifestations
at the time of admission, diagnostic evaluations,
pathogenesis and treatment of HSVE. We searched the
articles published from 1980 to 2006 in Medline and
EMBASE. The search included information related to
the research on human beings and in English.
The keywords were: Herpes Simplex Encephalitis, Viral
encephalitis, HSV meningoencephalitis, alone and with
epidemiology, definition, diagnostic tools, therapy and
treatment.
The reference list of the articles and other resources,
such as textbooks, were also reviewed.
The final choice of literature and the references were
based on our judgment of their relevancy to our subject.
Recommendations were based on our own knowledge
and clinical experiences.
Epidemiology
HSV-1 is the most common cause of sporadic encephalitis
and has been identified in 10-20% of cases of encephalitis
in some studies (4). The lower percentages of HSV-1
cases reported in some studies (3%) reflects the difficulty
of physician's practices to confirm the diagnosis (5,6).
There is a bimodal distribution of HSVE, with one third
of cases occurring in those younger than 20 years old
and one half in those older than 50 years old. The bimodal
age distribution may reflect the primary HSV infection
in the younger age group and
 the reactivation of latent HSV in older patients(7).
There is a predominance of males with a male to female
ratio of 2:1(8).
No seasonal or gender factors have been defined yet
relating to the incidence of HSE cases (9).
Both types 1 and 2 may cause neonatal HSV
meningoencephalitis(10).
More than two third of encephalitis cases due to HSV-
1 seems to result from reactivation of endogenous latent
HSV-1 in individuals previously exposed to the virus;
the other cases without any evidence of prior exposure
to HSV seems to be affected due to a primary infection
of HSV(9, 11). Cases of HSV-2 encephalitis usually
imply the primary infection rather than reactivation (12).
Some cases of HSV-2 meningoencephalitis have been
reported in adult patients with AIDS (13,14).
In recurrent herpes labialis, whereby the reactivation of
virus from the trigeminal ganglia occurs, HSE is a very
uncommon event (15).
Clinical presentation
Currently, HSE is estimated to occur in about 1 in 250,000
to 1 in 500,000 individuals per year(15).
The various clinical presentations are often unreliable,
as numerous neurological syndromes could mimic HSVE.
The classic presentation of HSVE is the sudden onset of
fever, headache, focal neurological signs, seizure, and/or
deterioration of consciousness (3).
Meningial signs are uncommon (16).
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In some studies the incidence of some of the clinical
manifestations might vary compared with the information
in table 1 (16).
The clinical findings at the time of admission in 18
children with the diagnosis of HSE are listed in table 2
based on the study of Karimi A et al (Under Publication).
The frequency of headache and CSF pleocytosis are higher
in patients with confirmed HSE than in patients with
diseases that mimic HSE. Irrespective of age, the typical
patients with HSE present with fever and changes in
personality. Seizures, whether focal or generalized, occur
in only about two third of the patients with confirmed
disease(17).
Patients with meningitis typically have headache, nuchal
rigidity and fever, but there isn't any altered sensorial or
focal  neurological findings (18).
It is recommended the diagnosis of HSVE must be
suspected in all cases of febrile diseases accompanied
with headache, altered level of consciousness, and signs
and symptoms of cerebral dysfunction.
Physical examination
The Physical exam consists of a combination of general
and neurological examinations.
HSV-1 encephalitis might be accompanied with
Gastrointestinal and upper respiratory manifestations (1).
The presence of oral or genital lesions is of no help in
the diagnosis or exclusion of HSV encephalitis. No
correlation exists between isolating HSV from sites
extrinsic to CNS and the diagnosis of HSVE (16).
In neurological examination, the existence of behavioral,
cognitive and focal neurological signs and seizures indicate
the brain malfunction.
The severity of clinical signs depends on the condition
of the patient immune system and his/her age. The very
young and the very old patients manifest the most serious
signs of encephalitis (1). Despite this, the diagnosis of
HSV infection should carefully be considered even in
patients with mild or atypical presentations of encephalitis
(19).
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Diagnostic investigations
The diagnosis is based on any two of the followings:
(1) A compatible clinical pattern
(2) Isolation of the virus
(3) Development of specific antibodies
(4) Demonstration of characteristic cells, histological
changes, viral antigen, or HSV DNA in scraping
CSF, or biopsy material (10).
CSF
CSF analysis is indicated in patients with altered
mental states, provided it is not contraindicated
because of increased intracranial pressure. Because
of the similarity of CSF analysis results in confirmed
disease and those mimicking HSE, CSF findings are
nondiagnostic in patients with HSE (17).
CSF analysis displays elevated levels of mononuclear
cells and proteins. As the disease progresses, both
protein and WBC count raise.
The protein level averages approximately to
100mg/dl. Elevated protein is reported in 80% of
patients which rises to the striking levels as the
disease progresses (9, 19, 20).
Early in infection, the neutrophils might be dominant,
a lymphocytic pleocytosis of about 10-500 cells/mm3
occurs in 85% of HSE patients, while less than 8%
of patients with biopsy or PCR-proven disease are
reported to have a normal CSF cell count. RBCs are
frequently detected in the CSF (10, 16). The presence
of red blood cells is not diagnostic for HSE.
Also there might be a mild hypoglycorrhachia (11).
In Karimi et al study (Under Publication), CSF
analysis in 18 children with HSE resulted the CSF
pleocytosis in 33.3% of cases, RBC detection in
61% of them and elevated levels of CSF protein in
50% of cases.
Nearly 5-10% of patients have a normal CSF results
on the first admission. The later observations should
be carry out especially in children in whom the
presentations include fever, encephalopathy, altered
mental state, and initially normal CSF examinations.
However, repeating the CSF analysis even within
24 hours will usually reveal abnormalities (15).
EEG
In 80% of the patients there is typical findings in
EEG .There is a temporal focus showing periodic
lateralized epileptiform discharge as well as the
background slowing (21). These findings are
suggestive but  not  pathogonomic (16).
In the early stages of disease, the abnormal electrical
activities usually involve one temporal lobe and then
spread to the contralateral temporal lobe as the
disease evolves (22).
These changes in EEG are observed within the first
5-7 days of illness (23, 24).
CT
CT findings may be characteristic late in illness and
consist of low-density, contrast -enhanced lesions
in the temporal lobe, mass effect, edema, and
hemorrhage; early in the illness, when diagnosis is
critical , CT findings are more often unremarkable
(16).
30-40% of patients might have normal CT scan (8).
Follow up imagings 1-2 weeks after the disease
onset demonstrate more widespread abnormalities
with involving contralateral lobe, insula and cingulate
gyrus.
In Panagariya A study, CT scan showed asymmetric
fronto-temporal lesions with or without hemorrhage
in 64% of cases (8).
According to Karimi A et al study (Under
Publication), 81% of patients which undergone brain
CT scan had shown abnormal changes (4 patients:
hyperdensity in temporal lobe, 3 patients: brain
edema, 2 patients: brain hemorrhage).
MRI
MRI is more sensitive and specific than CT for
evaluating viral encephalitis (25).
Findings include hyperintensity of the temporal lobe
on T2-weighted images with gadolinium
enhancement. MRI findings may be abnormal at the
initial evaluation of HSVE because of its high
sensitivity to the changes in brain water content (16).
Of 8 children who did brain MRI in Karimi A et al
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study (Under Publication), 22% had temporal lobe
hyperintensi ty on T2-weighted images.
Typical early findings include gyral edema on T1
weighted imaging (T1W1) and high signal intensity
in the temporal lobe or cingulate gyrus on T2W1,
FLAIR and DW1 and later hemorrhage.
Hypointensity on T1, hyperintensity on T2W1,
FLAIR, high signal on DW1 are other findings (26).
PCR
PCR technology provides the most convenient test.
Prior to the advent of PCR, brain biopsy with virus
isolation -which has a specificity of 100%-was the
accepted standard method of diagnosis (27).
PCR has a sensitivity of 98-99% and a specificity
of 94-100%.(8, 27).
HSV DNA PCR from CSF was done in 9 patients
with HSE in Karimi A et al study (Under Publication)
and 8 patients had positive DNA PCR in CSF.
PCR analysis can confirm the positive results one
day after the onset of symptoms. However, the
negative result does not essentially exclude the
diagnosis (16).
In the patients with a high likelihood of HSE (e.g.
typical EEG, MRI or CSF pleocytosis) a negative
test only reduces the disease likelihood to about 5%.
In patients with the low likelihood of HSE, a negative
CSF HSV PCR result reduces disease likelihood to
less than 1 % ( 28 , 29).
PCR analysis allows the antiviral therapy to be
performed efficiently and helps to detect the existence
of a resistant strain of the virus (1).
Although PCR analysis of CSF for HSV DNA is
the gold standard for diagnosis of HSE, supportive
techniques such as neuroimaging, EEG and
examination of CSF may also be favorable in
establishing the diagnosis of disease (29).
Quantitative HSV PCR is known to be valuable in
determining the prognosis of HSV encephalitis (30).
In one study, the morbidity and mortality rates were
higher in patients with a high copy number (more
than 100 HSV DNA copies/mm3 of CSF) than in
those with lower copy numbers. In general, higher
levels of HSV DNA were reported in the CSF
analysis of patients with a longer duration of
symptoms; patients with a high copy number had a
mean of 6.5+ 3 days of symptoms compared with
3.8+3 days of symptoms for those with the less
DNA in their CSF (30).
In another study, it has been shown there wasn't any
obvious correlation among HSV-1 load in the CSF
and the severity of clinical signs or the findings in
cranial imaging and the overall outcome (29, 31).
However, the amount of HSV-1 DNA in the CSF
decreases following the Acyclovir therapy.
Serology
CSF (intrathecal) antibody measurements are not
recommended for acute diagnostic purposes.
Intrathecal HSV antibody response might be helpful
to confirm the diagnosis in the cases in which the
PCR is negative because of the late sampling of
CSF from the onset of disease.
In children and young adults, HSV serology might
be helpful to define whether the HSE is a result of
a primary or reactivated HSV infection, although
the clinical features, therapy, and prognosis of both
types of HSVE are similar (29).
Brain biopsy
Brain biopsy has to be considered in the patients
who have negative PCR results despite of having
typical  signs and symptoms of HSVE.
Decision of analysis suggests that obtaining a biopsy
is especially critical in a patient with low CSF
glucose levels (16).
Brain biopsy is worthwhile in confusing clinical
presentations and acute or chronic complications
which occur in about 3% of patients (15).
Differential diagnosis
Sometimes it is very difficult to distinguish the
HSVE and other diseases. Especially in the children,
the likelihood of distinguishing HSVE from other
similar diseases is poor (16).
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Treatment
The first antiviral drug reported to be efficient in treating
HSE was Idoxuridine; however, in a controlled clinical
trial the drug has been proved to be not only ineffective
but also toxic (15).
Subsequent therapeutic trials presented Vidarabine as an
efficient medication for managing biopsy-proven HSE;
after a while this drug was also replaced by Acyclovir
following further investigations.
The current standard of therapy for HSVE in children is
intravenous Acyclovir (10 mg/kg/dose given over 1-hour
q8hr for 14-21 days) (32, 33, 34, 35).
Acyclovir decreases the mortality rate to 19%, Six months
after the beginning of therapy. Importantly, 38% of
patients, irrespective of age, recover and return to the
normal function. However, conversely, most patients are
left with significant neurologic impairment (15).
Returning to the normal activity is more likely in young
patients (less than 30 yrs old) with the better consciousness
state than older patients who are semicomatose or
comatose. Notably, 90% of individuals younger than 30
years old were children and adults.
New therapeutic protocols, such as anti-inflammatory
agents and antiapoptotic agents should be explored (29).
Prognosis
The mortality rate in untreated HSVE patients is about
70 percent, and the survivors generally suffer severe and
permanent neurological disabilities.
In patients with HSVE the prognosis for survival or for
recovery without serious permanent residua is guarded.
Early diagnosis and therapy improve the outcome (10,
16).
The outcome of Acyclovir therapy in children depends
on factors such as:
-Age
-the level of consciousness at the time of admission
-Duration of encephalitis
-Viral load
Early onset of therapy in the first four days increases the
18-month survival from 72% to 92 % ( 29, 33).
So it is strongly recommended to commence the Acyclovir
therapy as soon as the diagnosis is suspected, while the
investigations are in progress.
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